Anavex Life Sciences
AVXL
AVXL
144 hedge funds and large institutions have $206M invested in Anavex Life Sciences in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 44 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.47% less ownership
Funds ownership: 34.74% → 31.27% (-3.5%)
11% less capital invested
Capital invested by funds: $232M → $206M (-$25.9M)
Holders
144
Holding in Top 10
–
Calls
$9.63M
Puts
$5.85M
Top Buyers
| 1 | +$3.36M | |
| 2 | +$1.64M | |
| 3 | +$1.53M | |
| 4 |
Millennium Management
New York
|
+$1.38M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$727K |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$4.7M | |
| 3 | -$2.86M | |
| 4 |
Citigroup
New York
|
-$2.06M |
| 5 |
Two Sigma Advisers
New York
|
-$1.25M |